Cover Image

Adverse Drug Reactions Caused by Antimicrobials Treatment for Ventilator-Associated Pneumonia

Saved in:

Bibliographic Details
Main Authors:	Shan Shen (Author), Ning Hou (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Drug Prevention and Control of Ventilator-Associated Pneumonia
by: Xinming Xie, et al.
Published: (2019)

Meropenem plus Ertapenem and Ceftazidime-Avibactam plus Aztreonam for the Treatment of Ventilator Associated Pneumonia Caused by Pan-Drug Resistant <i>Klebsiella pneumonia</i>
by: Konstantinos Mantzarlis, et al.
Published: (2024)

Ventilator associated pneumonia
by: Sham Lohiya, et al.
Published: (2019)

Ventilator-associated pneumonia
by: Pradeep Rangappa
Published: (2023)

Ventilator-associated pneumonia
by: R Sanketh, et al.
Published: (2023)

Impact of Empirical Antimicrobial Treatment on Patients with Ventilator-Associated Pneumonia Due to <i>Stenotrophomonas maltophilia</i>
by: Pirawan Khunkit, et al.
Published: (2024)

Prevention and treatment of ventilator-associated pneumonia in COVID-19
by: Jiayi Deng, et al.
Published: (2022)

Acinetobacter baumannii Ventilator-Associated Pneumonia: Clinical Efficacy of Combined Antimicrobial Therapy and in vitro Drug Sensitivity Test Results
by: Yuqin Huang, et al.
Published: (2019)

Management of Ventilator-Associated Pneumonia: Quality Assessment of Clinical Practice Guidelines and Variations in Recommendations on Drug Therapy for Prevention and Treatment
by: Hong-Yan Li, et al.
Published: (2022)

Neonatal Ventilator Associated Pneumonia: A Quality Improvement Initiative Focusing on Antimicrobial Stewardship
by: Anouk Goerens, et al.
Published: (2018)

Effect of Nebulized Eucalyptus on Ventilator Associated Pneumonia in Ventilated Patients
by: Nazanin Amini, et al.
Published: (2019)

Cost-effectiveness analysis of CTZ/TAZ for the treatment of ventilated hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in Japan
by: Risako Takaya, et al.
Published: (2024)

Clinical Efficacy and In Vitro Drug Sensitivity Test Results of Azithromycin Combined With Other Antimicrobial Therapies in the Treatment of MDR P. aeruginosa Ventilator-Associated Pneumonia
by: Yuqin Huang, et al.
Published: (2022)

Model Based Evaluation of Hypersensitivity Adverse Drug Reactions to Antimicrobial Agents in Children
by: Abdelbaset A. Elzagallaai, et al.
Published: (2021)

Potential of drug interactions as a cause of adverse drug reactions in patients with kidney diseases
by: Tahereh Gholipur Shahraki, et al.
Published: (2020)

Ventilator associated pneumonia and infection control
by: Alp Emine, et al.
Published: (2006)

Ventilator-Associated Pneumonia in Immunosuppressed Patients
by: Louis Kreitmann, et al.
Published: (2023)

Antimicrobial Susceptibility among Pathogens Isolated in Early- versus Late-Onset Ventilator-Associated Pneumonia
by: Hend Ben Lakhal, et al.
Published: (2021)

HLA‐associated adverse drug reactions ‐ scoping review
by: Chiara Jeiziner, et al.
Published: (2021)

Predicting Drugs Suspected of Causing Adverse Drug Reactions Using Graph Features and Attention Mechanisms
by: Jinxiang Yang, et al.
Published: (2024)

Molecular Epidemiology and Risk Factors of Ventilator-Associated Pneumonia Infection Caused by Carbapenem-Resistant Enterobacteriaceae
by: Bo Gao, et al.
Published: (2019)

Causes of Drug-Induced Severe Cutaneous Adverse Reaction Epidermal Necrolysis (EN): An Analysis Using FDA Adverse Event Reporting System (FAERS) Database
by: Fei W, et al.
Published: (2023)

Adverse cutaneous drug reaction
by: Nayak Surajit, et al.
Published: (2008)

Adverse reactions of hypolypidemic drugs
by: Fidel Manuel Cáceres Lóriga Manuel Cáceres Lóriga, et al.
Published: (2014)

Viral isolates in pediatric ventilator-associated pneumonia
by: Bhawani Shankar Parihar, et al.
Published: (2022)

An Improved Algorithm for the Detection of Ventilator Associated Pneumonia
by: Dan Ding, et al.
Published: (2024)

Oral Health Impact on Ventilator-Associated Pneumonia
by: Bailey Miles, et al.
Published: (2024)

Clinical Practice Guidelines for Ventilation Associated Pneumonia.
by: Marcos Diosdado Iraola Ferrer, et al.
Published: (2009)

Clinical Practice Guidelines for Ventilation Associated Pneumonia.
by: Marcos Diosdado Iraola Ferrer, et al.
Published: (2009)

Analyzing Factor that Affecting of Ventilator Associated Pneumonia
by: Yuliyana Kumaladewi, et al.
Published: (2018)

Empirical Antibiotic Therapy for Ventilator-Associated Pneumonia
by: Diana L. Wells, et al.
Published: (2013)

Pneumonia associated with the mechanical ventilation in children and adolescents
by: Enrique Céspedes Floirian, et al.
Published: (2021)

Nurses\' Performance in Prevention of Ventilator associated Pneumonia
by: Fatemeh Behesht Aeen, et al.
Published: (2013)

Nurses\\\' Performance in Prevention of Ventilator associated Pneumonia
by: Fatemeh Behesht Aeen, et al.
Published: (2014)

Open and Closed Suction Ventilator Associated Pneumonia Prevention of Patient On Ventilator Installed
by: Supriandi Supriandi, et al.
Published: (2015)

Common causes and characteristics of adverse drug reactions in older adults: a retrospective study
by: Seong-Dae Woo, et al.
Published: (2020)

The Use of Antibiotics for Ventilator-Associated Pneumonia in the MIMIC-IV Database
by: Rui Yang, et al.
Published: (2022)

Treatments that generate higher number of adverse drug reactions and their symptoms
by: Lucía Fernández-López, et al.
Published: (2015)

Causes of adverse events in home mechanical ventilation: a nursing perspective
by: Myriam Lipprandt, et al.
Published: (2022)

The Top-100 Highly Cited Original Articles on Drug Therapy for Ventilator-Associated Pneumonia
by: Chao-Yang Wang, et al.
Published: (2019)